Upload
ledien
View
219
Download
3
Embed Size (px)
Citation preview
UK Market Leader Connected Healthcare IT
Overview
• Formed 1987 by two medical general practitioners
• MBO 2009, IPO 2010
Now uniquely ubiquitous in connected healthcare:
• Primary & Community care including:
– General practitioners
– Community, child and mental healthcare (CCMH)
– Patient health & wellbeing
• Community pharmacy
• Specialist & Secondary care
Primary care
• Market leader – over 50%
• Hosted solutions being rolled out across the estate to match demand
• Centrally funded through NHS
• Growth – contracted product development/volumetrics and further hosted roll-out in England, Wales and Scotland
UK Market Leader Connected Healthcare IT
Child, Community Mental Health
• Growing presence
• Hosted solution based on primary care system
• Locally funded by NHS
• Growth as former national contracts re-let in 2014/2015
UK Market Leader Connected Healthcare IT
Patient health & wellbeing
• Market leading independent health portal
• 18m visitors and 30m unique page impressions monthly
• Clinical transactional services: – Online appointment booking
– Repeat prescriptions
– Record viewing
– Centrally funded through NHS
• Growth – advertising revenue and transactional service fees
UK Market Leader Connected Healthcare IT
Community pharmacy
• Single most widely used UK dispensary system
• Hostable solution being developed
• Locally funded by customers or wholesalers
• Growth into “supermarket” estate
UK Market Leader Connected Healthcare IT
Specialist
• Growing presence and market
leader in diabetic retinopathy
• Hosted solutions based on
primary care system or stand
alone
• Locally funded by NHS
• Growth as long term conditions
increase
UK Market Leader Connected Healthcare IT
Secondary
• Leading products including A&E,
hospital pharmacy and PAS
• Hosted solutions or stand alone
• Locally funded by NHS
• Growth as former national
contracts re-let
UK Market Leader Connected Healthcare IT
Financial KPIs – H1 2014
(1) Excludes capitalisation and amortisation of development costs and amortisation of acquired intangibles. EPS calculations also adjust for related tax and non-controlling interest impact.
(2) Adjusted to exclude development costs capitalised of £3.5m (2013 H1: £2.7m).
Total revenue £66.4m (2013 H1: £47.1m), up 41% (organic 10%)
Recurring revenue £49.9m (2013 H1: £36.0m), up 39%
Adjusted group operating profit(1) £14.6m (2013 H1: £11.6m), up 27% (organic 10%)
- Reported - £12.9m (2013 H1: £12.1m), up 7%
Cash generated from operations(2) £27.0m (2013 H1: £19.0m), up 42%
Net debt £0.1m (2013 H2: £13.5m), down £13.4m
Adjusted EPS(1) 17.3p (2013 H1: 14.9p), up 16%- Reported – 15.2p (2013 H1: 15.6p), down 3%
Interim dividend 9.2p (2013 H1: 8.0p), up 15%